HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antoine G van der Heijden Selected Research

apaziquone (E 09)

6/2009Two-year follow-up of the phase II marker lesion study of intravesical apaziquone for patients with non-muscle invasive bladder cancer.
10/2006Phase II marker lesion study with intravesical instillation of apaziquone for superficial bladder cancer: toxicity and marker response.
4/2005Effect of hyperthermia on the cytotoxicity of 4 chemotherapeutic agents currently used for the treatment of transitional cell carcinoma of the bladder: an in vitro study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Antoine G van der Heijden Research Topics

Disease

22Urinary Bladder Neoplasms (Bladder Cancer)
06/2022 - 09/2003
9Non-Muscle Invasive Bladder Neoplasms
01/2021 - 06/2009
8Neoplasms (Cancer)
06/2022 - 04/2005
6Carcinoma (Carcinomatosis)
01/2022 - 04/2006
6Hyperthermia
01/2016 - 09/2003
1Lymphatic Metastasis
04/2022
1Neoplasm Metastasis (Metastasis)
01/2022
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2020
1Carcinoma in Situ
01/2019
1Transitional Cell Carcinoma
11/2004
1Body Weight (Weight, Body)
02/2004

Drug/Important Bio-Agent (IBA)

9Mitomycin (Mitomycin-C)FDA LinkGeneric
11/2018 - 09/2003
3apaziquone (E 09)IBA
06/2009 - 04/2005
2Cisplatin (Platino)FDA LinkGeneric
06/2022 - 01/2022
2Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2018
2Epirubicin (Ellence)FDA LinkGeneric
09/2014 - 04/2005
2GemcitabineFDA Link
04/2005 - 09/2003
1Carboplatin (JM8)FDA LinkGeneric
01/2022
1Biocompatible Materials (Biomaterials)IBA
01/2021
1DNA (Deoxyribonucleic Acid)IBA
01/2021
1PlatinumIBA
01/2021
1CytokinesIBA
10/2015
1Toll-Like Receptor 7IBA
06/2015
1Imiquimod (Aldara)FDA LinkGeneric
06/2015
1Tumor Biomarkers (Tumor Markers)IBA
10/2006
1Pharmaceutical PreparationsIBA
04/2006
1Pemetrexed (MTA)FDA Link
04/2006
15-aminolevulinic acid hexyl esterFDA Link
03/2005
1Amiloride (Midamor)FDA LinkGeneric
02/2004
1Chlorthalidone (Chlortalidone)FDA LinkGeneric
02/2004
1Colloids (Colloid)IBA
02/2004
1valrubicin (AD 32)FDA Link
09/2003
1pirarubicinIBA
09/2003

Therapy/Procedure

15Cystectomy
06/2022 - 09/2003
8Drug Therapy (Chemotherapy)
06/2022 - 04/2005
5Therapeutics
01/2020 - 09/2003
4Intravesical Administration
11/2020 - 10/2006
3Transurethral Resection of Bladder
01/2021 - 06/2009
3Immunotherapy
01/2020 - 01/2016
2Lymph Node Excision (Lymph Node Dissection)
04/2022 - 12/2014
2Radiotherapy
01/2020 - 09/2003
1Neoadjuvant Therapy
06/2022
1Urinary Diversion (Ileal Conduit)
11/2021
1Induced Hyperthermia (Thermotherapy)
01/2021
1Nephroureterectomy
01/2021
1Complementary Therapies (Alternative Medicine)
01/2019
1Photochemotherapy (Photodynamic Therapy)
09/2003